On the public citation graph

Systemic corticosteroids for the treatment of COVID-19: Equity-related analyses and update on evidence

https://doi.org/10.1002/14651858.cd014963.pub2
0 signed · 191 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jama.2020.16761openalex-snapshot
Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19
inferredcites →https://doi.org/10.1001/jama.2020.17021openalex-snapshot
Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19
inferredcites →https://doi.org/10.1001/jama.2020.17022openalex-snapshot
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19
inferredcites →https://doi.org/10.1001/jama.2020.17023openalex-snapshot
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19
inferredcites →https://doi.org/10.1001/jama.2020.2648openalex-snapshot
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
inferredcites →https://doi.org/10.1001/jama.2021.18295openalex-snapshot
Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia
inferredcites →https://doi.org/10.1001/jamanetworkopen.2022.0444openalex-snapshot
Geographical Representation of Low- and Middle-Income Countries in Randomized Clinical Trials for COVID-19
inferredcites →https://doi.org/10.1002/(sici)1097-0258(19981230)17:24<2815::aid-sim110>3.0.co;2-8openalex-snapshot
Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints
inferredcites →https://doi.org/10.1002/14651858.cd013600.pub2openalex-snapshot
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review
inferredcites →https://doi.org/10.1002/14651858.cd013600.pub4openalex-snapshot
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review
inferredcites →https://doi.org/10.1002/14651858.cd013665openalex-snapshot
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease
inferredcites →https://doi.org/10.1002/14651858.cd013825openalex-snapshot
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19
inferredcites →https://doi.org/10.1002/14651858.cd013825.pub2openalex-snapshot
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19
inferredcites →https://doi.org/10.1002/14651858.cd014962openalex-snapshot
Remdesivir for the treatment of COVID-19
inferredcites →https://doi.org/10.1002/14651858.cd014963openalex-snapshot
Systemic corticosteroids for the treatment of COVID-19
inferredcites →https://doi.org/10.1002/14651858.cd015045openalex-snapshot
Colchicine for the treatment of COVID-19
inferredcites →https://doi.org/10.1002/14651858.cd015125openalex-snapshot
Inhaled corticosteroids for the treatment of COVID-19
inferredcites →https://doi.org/10.1002/14651858.ed000155openalex-snapshot
It's time to increase the global relevance of Cochrane Reviews by applying an ‘equity lens’
inferredcites →https://doi.org/10.1007/s00134-021-06394-2openalex-snapshot
Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis
inferredcites →https://doi.org/10.1007/s00134-021-06573-1openalex-snapshot
Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial
inferredcites →https://doi.org/10.1007/s00508-020-01793-9openalex-snapshot
Sex and age differences in COVID-19 mortality in Europe
inferredcites →https://doi.org/10.1007/s00508-020-01805-8openalex-snapshot
Methylprednisolone in adults hospitalized with COVID-19 pneumonia
inferredcites →https://doi.org/10.1007/s15010-021-01594-wopenalex-snapshot
Clinical and virological characteristics of hospitalised COVID-19 patients in a German tertiary care centre during the first wave of the SARS-CoV-2 pandemic: a prospective observational study
inferredcites →https://doi.org/10.1007/s43440-021-00341-0openalex-snapshot
Comparing efficacy and safety of different doses of dexamethasone in the treatment of COVID-19: a three-arm randomized clinical trial
inferredcites →https://doi.org/10.1016/b0-12-341103-3/00122-4openalex-snapshot
Glucocorticoids, Pharmacology of
inferredcites →https://doi.org/10.1016/j.amjoto.2020.102884openalex-snapshot
Corticosteroid nasal spray for recovery of smell sensation in COVID-19 patients: A randomized controlled trial
inferredcites →https://doi.org/10.1016/j.cell.2020.08.001openalex-snapshot
Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment
inferredcites →https://doi.org/10.1016/j.chest.2021.07.1027openalex-snapshot
HIGH-DOSE VS LOW-DOSE DEXAMETHASONE IN PATIENTS WITH COVID-19 IN A TERTIARY HOSPITAL IN WESTERN HONDURAS
inferredcites →https://doi.org/10.1016/j.conctc.2021.100716openalex-snapshot
Pragmatic, open-label, single-center, randomized, phase II clinical trial to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus in patients with severe pneumonia secondary to COVID-19: The TACROVID trial protocol
inferredcites →https://doi.org/10.1016/j.eclinm.2021.101077openalex-snapshot
Ethnicity and acute hospital admissions: Multi-center analysis of routine hospital data
inferredcites →https://doi.org/10.1016/j.ejphar.2021.173947openalex-snapshot
No clinical benefit of high dose corticosteroid administration in patients with COVID-19: A preliminary report of a randomized clinical trial
inferredcites →https://doi.org/10.1016/j.ijid.2021.08.037openalex-snapshot
Risk factors associated with the mucormycosis epidemic during the COVID-19 pandemic
inferredcites →https://doi.org/10.1016/j.jclinepi.2009.06.005openalex-snapshot
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
inferredcites →https://doi.org/10.1016/j.jclinepi.2019.10.014openalex-snapshot
GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions
inferredcites →https://doi.org/10.1016/j.jclinepi.2019.10.015openalex-snapshot
GRADE guidelines 27: how to calculate absolute effects for time-to-event outcomes in summary of findings tables and Evidence Profiles
inferredcites →https://doi.org/10.1016/j.jclinepi.2020.04.025openalex-snapshot
An overview of platform trials with a checklist for clinical readers
inferredcites →https://doi.org/10.1016/s0140-6736(20)30183-5openalex-snapshot
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
inferredcites →https://doi.org/10.1016/s0140-6736(21)00634-6openalex-snapshot
Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform
inferredcites →https://doi.org/10.1016/s0140-6736(21)00949-1openalex-snapshot
COVID-19 and disparities affecting ethnic minorities
inferredcites →https://doi.org/10.1016/s0140-6736(22)00017-4openalex-snapshot
Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study
inferredcites →https://doi.org/10.1016/s1470-2045(20)30096-6openalex-snapshot
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
inferredcites →https://doi.org/10.1016/s1473-3099(20)30483-7openalex-snapshot
A minimal common outcome measure set for COVID-19 clinical research
inferredcites →https://doi.org/10.1016/s1473-3099(22)00320-6openalex-snapshot
Global impact of the first year of COVID-19 vaccination: a mathematical modelling study
inferredcites →https://doi.org/10.1016/s2213-2600(19)30417-5openalex-snapshot
Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial
inferredcites →https://doi.org/10.1016/s2213-2600(21)00160-0openalex-snapshot
Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial
inferredcites →https://doi.org/10.1016/s2214-109x(20)30285-0openalex-snapshot
Ethnic and regional variations in hospital mortality from COVID-19 in Brazil: a cross-sectional observational study
inferredcites →https://doi.org/10.1016/s2666-5247(21)00237-8openalex-snapshot
The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries
inferredcites →https://doi.org/10.1038/s41586-020-2521-4openalex-snapshot
Factors associated with COVID-19-related death using OpenSAFELY
inferredcites →https://doi.org/10.1038/s41591-022-01887-zopenalex-snapshot
Clinical outcomes associated with SARS-CoV-2 Omicron (B.1.1.529) variant and BA.1/BA.1.1 or BA.2 subvariant infection in Southern California
inferredcites →https://doi.org/10.1038/s41598-021-87692-zopenalex-snapshot
Climate and the spread of COVID-19
inferredcites →https://doi.org/10.1038/s41598-021-88086-xopenalex-snapshot
Short term survival of critically ill COVID-19 Egyptian patients on assisted ventilation treated by either Dexamethasone or Tocilizumab
inferredcites →https://doi.org/10.1038/sj.bjp.0706736openalex-snapshot
How corticosteroids control inflammation: Quintiles Prize Lecture 2005
inferredcites →https://doi.org/10.1053/j.jvca.2020.11.057openalex-snapshot
Corticosteroids for Patients With Coronavirus Disease 2019 (COVID-19) With Different Disease Severity: A Meta-Analysis of Randomized Clinical Trials
inferredcites →https://doi.org/10.1055/a-1334-1925openalex-snapshot
S2k-Leitlinie – Empfehlungen zur stationären Therapie von Patienten mit COVID-19
inferredcites →https://doi.org/10.1056/nejmoa2021436openalex-snapshot
Dexamethasone in Hospitalized Patients with Covid-19
inferredcites →https://doi.org/10.1056/nejmra050541openalex-snapshot
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
inferredcites →https://doi.org/10.1080/19466315.2020.1800509openalex-snapshot
Embedding a COVID-19 group sequential clinical trial within an ongoing trial: lessons from an unusual experience
inferredcites →https://doi.org/10.1093/cid/ciaa1177openalex-snapshot
Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With Coronavirus Disease 2019 (COVID-19; Metcovid): A Randomized, Double-blind, Phase IIb, Placebo-controlled Trial
inferredcites →https://doi.org/10.1093/pubmed/fdx008openalex-snapshot
Quantifying the global distribution of premature mortality from non-communicable diseases
inferredcites →https://doi.org/10.1097/cce.0000000000000280openalex-snapshot
Intravenous Immunoglobulin Plus Methylprednisolone Mitigate Respiratory Morbidity in Coronavirus Disease 2019
inferredcites →https://doi.org/10.1097/ccm.0000000000000247openalex-snapshot
Corticosteroids and Transition to Delirium in Patients With Acute Lung Injury*
inferredcites →https://doi.org/10.1097/ccm.0000000000003262openalex-snapshot
Corticosteroids in Sepsis: An Updated Systematic Review and Meta-Analysis
inferredcites →https://doi.org/10.1097/cm9.0000000000000791openalex-snapshot
Effectiveness of glucocorticoid therapy in patients with severe coronavirus disease 2019: protocol of a randomized controlled trial
inferredcites →https://doi.org/10.1097/jom.0000000000002274openalex-snapshot
The Correlation Between COVID-19 Activities and Climate Factors in Different Climate Types Areas
inferredcites →https://doi.org/10.1101/2020.08.01.20166678openalex-snapshot
Aprepitant as a combinant with Dexamethasone reduces the inflammation via Neurokinin 1 Receptor Antagonism in severe to critical Covid-19 patients and potentiates respiratory recovery: A novel therapeutic approach
inferredcites →https://doi.org/10.1111/aas.13673openalex-snapshot
Low‐dose hydrocortisone in patients with COVID‐19 and severe hypoxia (COVID STEROID) trial—Protocol and statistical analysis plan
inferredcites →https://doi.org/10.1111/aas.13795openalex-snapshot
Higher vs lower doses of dexamethasone in patients with COVID‐19 and severe hypoxia (COVID STEROID 2) trial: Protocol and statistical analysis plan
inferredcites →https://doi.org/10.1111/aas.13941openalex-snapshot
Low‐dose hydrocortisone in patients with COVID‐19 and severe hypoxia: The COVID STEROID randomised, placebo‐controlled trial
inferredcites →https://doi.org/10.1111/j.1365-2567.2007.02555.xopenalex-snapshot
Immunosenescence: emerging challenges for an ageing population
inferredcites →https://doi.org/10.1136/bmj.327.7414.557openalex-snapshot
Measuring inconsistency in meta-analyses
inferredcites →https://doi.org/10.1136/bmj.b2535openalex-snapshot
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
inferredcites →https://doi.org/10.1136/bmj.j1415openalex-snapshot
Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study
inferredcites →https://doi.org/10.1136/bmj.l4898openalex-snapshot
RoB 2: a revised tool for assessing risk of bias in randomised trials
inferredcites →https://doi.org/10.1136/bmj.m2980openalex-snapshot
Drug treatments for covid-19: living systematic review and network meta-analysis
inferredcites →https://doi.org/10.1152/ajpendo.00100.2011openalex-snapshot
Extra-adrenal glucocorticoids and mineralocorticoids: evidence for local synthesis, regulation, and function
inferredcites →https://doi.org/10.1159/000512063openalex-snapshot
Early Use of Corticosteroid May Prolong SARS-CoV-2 Shedding in Non-Intensive Care Unit Patients with COVID-19 Pneumonia: A Multicenter, Single-Blind, Randomized Control Trial
inferredcites →https://doi.org/10.1177/08850666211066799openalex-snapshot
High- Versus Low-Dose Dexamethasone for the Treatment of COVID-19-Related Acute Respiratory Distress Syndrome: A Multicenter, Randomized Open-Label Clinical Trial
inferredcites →https://doi.org/10.1183/13993003.02518-2021openalex-snapshot
Effect of highversuslow dose of dexamethasone on clinical worsening in patients hospitalised with moderate or severe COVID-19 pneumonia: an open-label, randomised clinical trial
inferredcites →https://doi.org/10.1183/13993003.02808-2020openalex-snapshot
Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial
inferredcites →https://doi.org/10.1186/1471-2288-11-144openalex-snapshot
How to handle mortality when investigating length of hospital stay and time to clinical stability
inferredcites →https://doi.org/10.1186/1745-6215-8-16openalex-snapshot
Practical methods for incorporating summary time-to-event data into meta-analysis
inferredcites →https://doi.org/10.1186/s12879-021-06045-3openalex-snapshot
Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial
inferredcites →https://doi.org/10.1186/s12931-021-01833-6openalex-snapshot
The efficacy of corticosteroids therapy in patients with moderate to severe SARS-CoV-2 infection: a multicenter, randomized, open-label trial
inferredcites →https://doi.org/10.1186/s13054-020-03022-1openalex-snapshot
Acute complications and mortality in hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis
inferredcites →https://doi.org/10.1186/s13054-020-03400-9openalex-snapshot
Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes
inferredcites →https://doi.org/10.1186/s13054-021-03873-2openalex-snapshot
Early, biomarker-guided steroid dosing in COVID-19 Pneumonia: a pilot randomized controlled trial
inferredcites →https://doi.org/10.1186/s13063-020-04499-5openalex-snapshot
Letter to the editor: efficacy of different methods of combination regimen administrations including dexamethasone, intravenous immunoglobulin, and interferon-beta to treat critically ill COVID-19 patients: a structured summary of a study protocol for a randomized controlled trial
inferredcites →https://doi.org/10.1186/s13063-020-04575-wopenalex-snapshot
Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: A structured summary of a randomised controlled trial
inferredcites →https://doi.org/10.1186/s13063-020-04585-8openalex-snapshot
Efficacy of local budesonide therapy in the management of persistent hyposmia in COVID-19 patients without signs of severity: A structured summary of a study protocol for a randomised controlled trial
inferredcites →https://doi.org/10.1186/s13063-020-04645-zopenalex-snapshot
Multi-centre, three arm, randomized controlled trial on the use of methylprednisolone and unfractionated heparin in critically ill ventilated patients with pneumonia from SARS-CoV-2 infection: A structured summary of a study protocol for a randomised controlled trial
inferredcites →https://doi.org/10.1186/s13063-020-04646-yopenalex-snapshot
High dose dexamethasone treatment for Acute Respiratory Distress Syndrome secondary to COVID-19: a structured summary of a study protocol for a randomised controlled trial
inferredcites →https://doi.org/10.1186/s13063-020-04999-4openalex-snapshot
Treatment of COVID-19 pneumonia with glucocorticoids (CORTIVID): a structured summary of a study protocol for a randomised controlled trial
inferredcites →https://doi.org/10.1186/s13063-021-05046-6openalex-snapshot
Early use of corticosteroids in non-critical patients with COVID-19 pneumonia (PREDCOVID): a structured summary of a study protocol for a randomised controlled trial
inferredcites →https://doi.org/10.1186/s13098-020-00583-7openalex-snapshot
Dexamethasone in the era of COVID-19: friend or foe? An essay on the effects of dexamethasone and the potential risks of its inadvertent use in patients with diabetes
inferredcites →https://doi.org/10.1186/s13643-016-0384-4openalex-snapshot
Rayyan—a web and mobile app for systematic reviews
inferredcites →https://doi.org/10.12688/wellcomeopenres.15922.2openalex-snapshot
Black, Asian and Minority Ethnic groups in England are at increased risk of death from COVID-19: indirect standardisation of NHS mortality data
inferredcites →https://doi.org/10.1371/journal.pmed.1001333openalex-snapshot
PRISMA-Equity 2012 Extension: Reporting Guidelines for Systematic Reviews with a Focus on Health Equity
inferredcites →https://doi.org/10.1371/journal.pmed.1003346openalex-snapshot
Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis
inferredcites →https://doi.org/10.1371/journal.pntd.0009921openalex-snapshot
COVID-19–associated mucormycosis: Evidence-based critical review of an emerging infection burden during the pandemic’s second wave in India
inferredcites →https://doi.org/10.1371/journal.pone.0254809openalex-snapshot
The impact of race and ethnicity on outcomes in 19,584 adults hospitalized with COVID-19
inferredcites →https://doi.org/10.1513/annalsats.202003-192sdopenalex-snapshot
The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study. Rationale and Design
inferredcites →https://doi.org/10.21203/rs.3.rs-66909/v1openalex-snapshot
Evaluation of the Efficacy of Methylprednisolone Pulse Therapy in Treatment of Covid-19 Adult Patients with Severe Respiratory Failure: Randomized, Clinical Trial
inferredcites →https://doi.org/10.21518/2079-701x-2021-12-162-172openalex-snapshot
The role and place of glucocorticosteroids in treatment of COVID-19 pneumonia without hypoxemia
inferredcites →https://doi.org/10.2337/dc12-2197openalex-snapshot
Comorbid Diabetes and COPD
inferredcites →https://doi.org/10.25646/7111openalex-snapshot
Eine höhere Letalität und lange Beatmungsdauer unterscheiden COVID-19 von schwer verlaufenden Atemwegsinfektionen in Grippewellen
inferredcites →https://doi.org/10.2807/1560-7917.es.2021.26.16.2100348openalex-snapshot
Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021
inferredcites →https://doi.org/10.2807/1560-7917.es.2021.26.50.2101147openalex-snapshot
Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021
inferredcites →https://doi.org/10.3126/ajms.v12i12.39294openalex-snapshot
A comparative study of the efficacy and outcome of methylprednisolone and dexamethasone in moderate to severe COVID-19 disease
inferredcites →https://doi.org/10.3389/fimmu.2021.709861openalex-snapshot
Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A Pilot Study
inferredcites →https://doi.org/10.3389/fmed.2021.758405openalex-snapshot
Short-Course of Methylprednisolone Improves Respiratory Functional Parameters After 120 Days in Hospitalized COVID-19 Patients (Metcovid Trial): A Randomized Clinical Trial
inferredcites →https://doi.org/10.3390/jof5010026openalex-snapshot
Global Epidemiology of Mucormycosis
inferredcites →https://doi.org/10.4239/wjd.v12.i9.1401openalex-snapshot
Epidemiology of type 2 diabetes in the Middle East and North Africa: Challenges and call for action
inferredcites →https://doi.org/10.4239/wjd.v3.i6.110openalex-snapshot
Trends in prevalence of diabetes in Asian countries
inferredcites →https://doi.org/10.5935/0103-507x.20200063openalex-snapshot
COVID-19-associated ARDS treated with DEXamethasone (CoDEX): study design and rationale for a randomized trial
inferredcites →https://doi.org/10.7326/m20-0504openalex-snapshot
The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application
inferredcites →https://doi.org/10.7326/m20-3012openalex-snapshot
Prevalence of Asymptomatic SARS-CoV-2 Infection
inferredcites →https://doi.org/10.7759/cureus.20353openalex-snapshot
High-Dose Dexamethasone Versus Tocilizumab in Moderate to Severe COVID-19 Pneumonia: A Randomized Controlled Trial

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4735939openalex-extracted
Centering Racial Health Equity in Systematic Reviews Paper 6: Engaging racially and ethnically diverse stakeholders in evidence syntheses
inferred← citeshttps://doi.org/10.1002/14651858.cd015078openalex-snapshot
Antiplatelet agents for the treatment of adults with COVID-19
inferred← citeshttps://doi.org/10.1002/cca.3785openalex-snapshot
For adults hospitalized with acute or suspected COVID-19, what are the benefits and harms of systemic corticosteroids?
inferred← citeshttps://doi.org/10.1002/cca.4153openalex-snapshot
For adults hospitalized with acute or suspected COVID-19, what are the benefits and harms of systemic corticosteroids?
inferred← citeshttps://doi.org/10.1002/cesm.12038openalex-snapshot
Mechanical ventilation core outcome set uptake in Cochrane systematic reviews: A cross‐sectional study
inferred← citeshttps://doi.org/10.1002/cesm.12093openalex-snapshot
How to present an informative summary of findings table for systematic reviews of interventions: A tutorial
inferred← citeshttps://doi.org/10.1002/cesm.70054openalex-snapshot
Health Equity in Systematic Reviews: A Tutorial—Part 2 Implementing Health Equity Throughout Your Methods
inferred← citeshttps://doi.org/10.1002/cnr2.2103openalex-snapshot
Identifying risk factors for severe omicron infection in allogeneic hematopoietic stem cell transplant recipients with hematologic malignancies
inferred← citeshttps://doi.org/10.1007/s00134-025-07878-1openalex-snapshot
A critical assessment of corticosteroid trials for hospitalised patients with SARS-CoV-2 disease
inferred← citeshttps://doi.org/10.1007/s10787-024-01474-3openalex-snapshot
Outpatient glucocorticoid use and COVID-19 outcomes: a population-based study
inferred← citeshttps://doi.org/10.1007/s11686-024-00803-4openalex-snapshot
The Impact of Pulmonary Hydatid Cyst Rupture on COVID-19 Symptom Severity
inferred← citeshttps://doi.org/10.1016/b978-3-437-21035-8.00039-2openalex-snapshot
Literatur
inferred← citeshttps://doi.org/10.1016/j.anai.2024.08.021openalex-snapshot
Inflammatory pathways in patients with post-acute sequelae of COVID-19
inferred← citeshttps://doi.org/10.1016/j.cegh.2024.101867openalex-snapshot
Efficacy of corticosteroids in COVID-19: An evidence-based approach from the published randomized controlled trials
inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e35988openalex-snapshot
Repurposing existing drugs for the treatment ofCOVID-19/SARS-CoV-2: A review of pharmacological effects and mechanism of action
inferred← citeshttps://doi.org/10.1016/j.jclinepi.2024.111277openalex-snapshot
Study found increasing use of core outcome sets in Cochrane systematic reviews and identified facilitators and barriers
inferred← citeshttps://doi.org/10.1016/j.pharmthera.2025.108904openalex-snapshot
Unveiling the silent threat: COVID-19 and myocardial injury
inferred← citeshttps://doi.org/10.1016/j.redar.2023.09.002openalex-snapshot
Asociación entre diferentes pautas de corticoides empleadas en la infección grave por SARS-CoV-2 y la mortalidad a corto plazo: estudio de cohortes retrospectivo
inferred← citeshttps://doi.org/10.1016/j.redare.2024.02.012openalex-snapshot
Association between different corticosteroid regimens used in severe SARS-CoV-2 infection and short-term mortality: retrospective cohort study
inferred← citeshttps://doi.org/10.1016/j.rmed.2023.107373openalex-snapshot
Asthma in the era of COVID-19
inferred← citeshttps://doi.org/10.1016/j.zefq.2023.11.004openalex-snapshot
Experience report of two living systematic Cochrane reviews on COVID-19
inferred← citeshttps://doi.org/10.1038/s41598-024-67733-zopenalex-snapshot
Intensive care unit-acquired infections more common in patients with COVID-19 than with influenza
inferred← citeshttps://doi.org/10.1080/17476348.2025.2488966openalex-snapshot
Effectiveness of drugs employed in the treatment of COVID-19: real-world evidence
inferred← citeshttps://doi.org/10.1089/respcare.12494openalex-snapshot
Rebound Hypoxemia in Mechanically Ventilated Patients With COVID-19 Completing a Standard 10-Day Course of Corticosteroid Therapy
inferred← citeshttps://doi.org/10.1093/infdis/jiaf328openalex-snapshot
Host Immunomodulatory Interventions in Severe Influenza
inferred← citeshttps://doi.org/10.1093/med/9780199688876.003.0022openalex-snapshot
Respiratory disorders
inferred← citeshttps://doi.org/10.1093/ofid/ofad011openalex-snapshot
Correlates of Coronavirus Disease 2019 Inpatient Mortality at a Southern California Community Hospital With a Predominantly Hispanic/Latino Adult Population
inferred← citeshttps://doi.org/10.1097/ipc.0000000000001470openalex-snapshot
Application of Antirheumatic Drugs During the Epidemic Period of COVID-19
inferred← citeshttps://doi.org/10.1101/2023.04.05.23288189openalex-snapshot
Experiment aversion among clinicians and the public — an obstacle to evidence-based medicine and public health
inferred← citeshttps://doi.org/10.1164/rccm.202305-0890ocopenalex-snapshot
Host Response Changes and Their Association with Mortality in COVID-19 Patients with Lymphopenia
inferred← citeshttps://doi.org/10.1177/20499361251328824openalex-snapshot
The comparative effectiveness of methylprednisolone versus dexamethasone on in-hospital mortality in patients with severe or critical COVID-19: a retrospective observational study
inferred← citeshttps://doi.org/10.1183/2312508x.10020423openalex-snapshot
Therapeutics in hospitalised adult patients with COVID-19
inferred← citeshttps://doi.org/10.1186/s12879-024-09563-yopenalex-snapshot
Efficacy and safety of oral ivermectin in the treatment of mild to moderate Covid-19 patients: a multi-centre double-blind randomized controlled clinical trial
inferred← citeshttps://doi.org/10.1186/s12879-024-09879-9openalex-snapshot
Outcomes of COVID-19 in 24 hospitalized liver transplant recipients: an observational study
inferred← citeshttps://doi.org/10.1186/s12890-025-03659-0openalex-snapshot
Corticosteroids and long-term pulmonary function after critical illness due to COVID-19– a single-center cohort study
inferred← citeshttps://doi.org/10.1186/s12890-025-03874-9openalex-snapshot
Early C-reactive protein reduction predicts survival in COVID-19 severe pneumonia treated with glucocorticoids
inferred← citeshttps://doi.org/10.1186/s12936-025-05315-8openalex-snapshot
Coinfection of COVID-19 and malaria: clinical profiles, interactions, and strategies for effective control
inferred← citeshttps://doi.org/10.1186/s12985-024-02345-7openalex-snapshot
Efficacy of different doses of corticosteroids in treating severe COVID-19 pneumonia
inferred← citeshttps://doi.org/10.1186/s13054-023-04337-5openalex-snapshot
Intravenous methylprednisolone pulse therapy and the risk of in-hospital mortality among acute COVID-19 patients: Nationwide clinical cohort study
inferred← citeshttps://doi.org/10.1186/s13613-023-01168-zopenalex-snapshot
Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian post-hoc reanalysis of the COVIDICUS randomized clinical trial
inferred← citeshttps://doi.org/10.1186/s13643-025-02976-zopenalex-snapshot
Methylprednisolone versus dexamethasone in hospitalized patients with severe COVID-19: a systematic review and meta-analysis of randomized controlled trials
inferred← citeshttps://doi.org/10.1186/s13643-026-03209-7openalex-snapshot
Compliance with existing standards: overview comparing Cochrane with non-Cochrane living systematic reviews
inferred← citeshttps://doi.org/10.1186/s40001-024-02215-6openalex-snapshot
Effects of two different dexamethasone dosing regimens on ventilator-free days and long-term mortality in COVID-19 patients with moderate-to-severe ARDS: the REMED randomized clinical trial
inferred← citeshttps://doi.org/10.12659/msm.940965openalex-snapshot
Corticosteroid-Associated Avascular Necrosis of the Femoral Head in Patients with Severe COVID-19: A Single-Center Study
inferred← citeshttps://doi.org/10.1371/journal.pone.0280079openalex-snapshot
A hyperinflammation clinical risk tool, HI5-NEWS2, stratifies hospitalised COVID-19 patients to associate risk of death and effect of early dexamethasone in an observational cohort
inferred← citeshttps://doi.org/10.20944/preprints202307.0627.v1openalex-snapshot
Suffocation in asthma and COVID-19: Supplementation of inhaled corticosteroids with alkaline hydrogen peroxide as an alternative to ECMO
inferred← citeshttps://doi.org/10.21203/rs.3.rs-10630305/v1openalex-snapshot
Prognostic Efficacy of Pulse-Dose versus Standard Low-Dose Corticosteroids in Severe COVID-19 ARDS
inferred← citeshttps://doi.org/10.21203/rs.3.rs-2687554/v1openalex-snapshot
‘Which severe COVID-19 patients could benefit from High dose dexamethasone? A Bayesian reanalysis of a randomized clinical trial
inferred← citeshttps://doi.org/10.21275/sr24302034654openalex-snapshot
Analysis and Efficacy of Current Therapeutic Options for the Treatment of SARS-CoV-2
inferred← citeshttps://doi.org/10.2147/idr.s432679openalex-snapshot
During the Omicron Pandemic Wave, the Severe Systemic Inflammatory Status of COVID-19 Indicated a Higher Risk of In-Hospital Mortality and Mediated the Clinical Efficacy of Corticosteroids
inferred← citeshttps://doi.org/10.2147/jir.s406658openalex-snapshot
The Diagnostic Value of Inflammatory Markers (CRP, IL6, CRP/IL6, CRP/L, LCR) for Assessing the Severity of COVID-19 Symptoms Based on the MEWS and Predicting the Risk of Mortality
inferred← citeshttps://doi.org/10.21518/ms2024-064openalex-snapshot
Clinical efficacy of various regimens of systemic glucocorticoids therapy in COVID-19 patients
inferred← citeshttps://doi.org/10.2174/0115680266322046240819053909openalex-snapshot
Catalase: A Potential Pharmacologic Target for Hydrogen Peroxide in the Treatment of COVID-19
inferred← citeshttps://doi.org/10.22328/2077-9828-2023-15-3-105-115openalex-snapshot
Medical technologies assessment in COVID-19
inferred← citeshttps://doi.org/10.3138/cim.v46i4e03openalex-snapshot
Efficacy and Safety of Glucocorticoid in the Treatment of Acute Respiratory Distress Syndrome caused by Covid-19: A Systematic Review and Meta-Analysis
inferred← citeshttps://doi.org/10.3238/arztebl.m2025.0225openalex-snapshot
Mechanical Ventilation and Extracorporeal Membrane Oxygenation in Acute Respiratory Insufficiency
inferred← citeshttps://doi.org/10.3389/fmicb.2026.1916526openalex-snapshot
Hyperinflammation and immunomodulation in influenza, SARS-CoV-2 and syncytial respiratory virus infection in adults: from innate immune responses and biomarkers to clinical and therapeutic implications
inferred← citeshttps://doi.org/10.3389/fneur.2026.1853951openalex-snapshot
Pathogen effects on the brain: the case of SARS-CoV-2 spike protein and neuro COVID
inferred← citeshttps://doi.org/10.3389/fphar.2023.1299613openalex-snapshot
Pharmacokinetics of recombinant human annexin A5 (SY-005) in patients with severe COVID-19
inferred← citeshttps://doi.org/10.3390/biomedicines13061482openalex-snapshot
Post-COVID Metabolic Fallout: A Growing Threat of New-Onset and Exacerbated Diabetes
inferred← citeshttps://doi.org/10.3390/cells12050688openalex-snapshot
Role of SARS-CoV-2 Spike-Protein-Induced Activation of Microglia and Mast Cells in the Pathogenesis of Neuro-COVID
inferred← citeshttps://doi.org/10.3390/jcdd11100319openalex-snapshot
Prognostic Value of Coronary Artery Calcification in Patients with COVID-19 and Interstitial Pneumonia: A Case-Control Study
inferred← citeshttps://doi.org/10.3390/jcm13051341openalex-snapshot
Isolated Depo-Medrol Administration under Tenon’s Capsule for Post-COVID-19 Uveitis in a Child: A Case Report and Literature Review
inferred← citeshttps://doi.org/10.3390/microorganisms11122959openalex-snapshot
Long COVID or Post-COVID-19 Condition: Past, Present and Future Research Directions
inferred← citeshttps://doi.org/10.3390/v17060822openalex-snapshot
Steroid Pulse Therapy Leads to Secondary Infections and Poor Outcomes in Patients with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Intensive Care Units: A Retrospective Cohort Study
inferred← citeshttps://doi.org/10.36290/far.2025.018openalex-snapshot
Clinically relevant drug-drug interactions with nirmatrelvir/ritonavir in patients on chronic pharmacotherapy
inferred← citeshttps://doi.org/10.37349/emed.2025.1001314openalex-snapshot
The viral oncogenesis of COVID-19 and its impact on cancer progression, long-term risks, treatment complexities, and research strategies
inferred← citeshttps://doi.org/10.3904/kjim.2023.046openalex-snapshot
Corticosteroids for non-severe COVID-19 infections? Too early to conclude
inferred← citeshttps://doi.org/10.4103/tcmj.tcmj_219_22openalex-snapshot
Coronavirus disease 2019 and cardiovascular disease
inferred← citeshttps://doi.org/10.56016/dahudermj.1582147openalex-snapshot
Outcomes of Steroid and Pulse Steroid Therapies in COVID-19 Inpatients Requiring Oxygen Therapy, Retrospective Case Control Study
inferred← citeshttps://doi.org/10.6026/97320630019939openalex-snapshot
Epidemiology, clinical presentation and treatment outcomes in patients with COVID-19 in an ambulatory setting: a cross sectional study during the massive SARS-CoV-2 wave in India
inferred← citeshttps://doi.org/10.6084/m9.figshare.26613185openalex-snapshot
Additional file 1 of Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian post-hoc reanalysis of the COVIDICUS randomized clinical trial
inferred← citeshttps://doi.org/10.6084/m9.figshare.26613188openalex-snapshot
Additional file 2 of Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian post-hoc reanalysis of the COVIDICUS randomized clinical trial
inferred← citeshttps://doi.org/10.63729/tjic.2025.642openalex-snapshot
COVID-19 yoğun bakımda takip edilen ARDS hastalarında iki farklı deksametazon dozunun hiperinflamasyon üzerine etkinliğinin retrospektif olarak değerlendirilmesi
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.